- This event has passed.
Joy Goodwin Lecture
April 24 @ 1:00 pm - 2:00 pm
Dr. Steven Stice, director of the Regenerative Bioscience Center at the University of Georgia, will provide a Joy Goodwin Lecture on “Manipulation of Mesenchymal Stem Cells for Orthopedic Regenerative Therapies” on Wednesday, April 24, at 1 p.m. in 255 Veterinary Education Center.
He will also speak on Thursday, April 25, at 11 a.m. in 255 VEC on “Neural Stem Cell Derived Exosomes Enhance Recovery in a Porcine Stroke Model.” Stice, Georgia Research Alliance Eminent Scholar endowed chair, DW Brooks Distinguished Professor and Director of the University of Georgia’s Regenerative Bioscience Center, is co-founder of five biotech start-ups, including ArunA Bio; the first company to commercialize a stem cell product used to facilitate approval of Pfizer’s in use cognitive enhancing pharmaceuticals. A 30-year veteran researcher in bio-manufacturing technologies and regenerative medicine, he is world-renowned for developing the first human pluripotent stem cell (hPSC), which has led to 16 U.S. patents in stem cells, animal biotechnology and regenerative medicine. He produced the first cloned rabbit and the first cloned transgenic calves, and launched the first company to commercialize a therapy based on federally approved stem cell lines.
Stice continues to add to his first-to-market innovations. Working in collaboration with his startup; ArunA Bio, he is currently developing a new Exosome treatment for stroke that has shown to reduce brain damage and accelerate the brain’s natural healing tendencies, in two divergent animal species and two stroke types. As an invited member, he sits on the Scientific Advisory Board for the Food and Drug Administration (FDA), and is serving on the Governing Committee of the first
institute funded by the U.S. Department Commerce (DOC); National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL). Stice chairs the UGA academic lead in a research consortium, based in Atlanta; Engineering Research Center for Cell Manufacturing Technologies (CMaT), which was recently funded $20 million by NSF. In 2018, The National Academy of Inventors (NAI) named Stice to Fellow status, the highest professional distinction accorded solely
to academic inventors. Regionally, he was honored with the Georgia Bio Industry Growth Award, for his longstanding commitment to growing the life science industry in Georgia, as well as, the advancement of regenerative medicine research and commercialization in the state.